VistaGen Therapeutics Inc. (NASDAQ: VTGN) Stock Information | RedChip

VistaGen Therapeutics Inc. (NASDAQ: VTGN)


$2.7650
+0.1850 ( +7.17% ) 159.9K

Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.

Market Data


Open


$2.7650

Previous close


$2.5800

Volume


159.9K

Market cap


$77.29M

Day range


$2.5700 - $2.7850

52 week range


$2.4800 - $5.8600

SEC Filings


Form Type Description Pages Date
8-k 8K-related 15 Nov 07, 2024
10-q Quarterly Reports 58 Nov 07, 2024
8-k 8K-related 15 Sep 23, 2024
4 Insider transactions 1 Sep 10, 2024
4 Insider transactions 1 Sep 10, 2024
4 Insider transactions 1 Sep 10, 2024
4 Insider transactions 1 Sep 10, 2024
4 Insider transactions 1 Sep 10, 2024
4 Insider transactions 1 Sep 10, 2024
8-k 8K-related 14 Aug 28, 2024

Latest News